Stock & Company Details
Kiniksa Pharmaceuticals Ltd $KNSA
Price:
46,691,331
46M
$6.1B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
KNSA technical indicators
Latest Kiniksa Pharmaceuticals Ltd (KNSA) technical indicators as of 2026-07-28: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
78.09 35.7%
MACD:
2.86 73.3%
SMA 50:
$57.40 0.7%
SMA 200:
$47.37 0.4%
EMA 20:
$63.56 2.7%
Bollinger Bands:
71.71 / 56.50
Stochastic:
57.43 39.2%
ADX 14:
33.82 9.7%
ATR 14:
3.50 48.9%
CCI 20:
483.65 1129.1%
OBV:
43.16M 7.1%
ROC 12:
25.22% 996.2%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.
Finance Bot
Ask your questions
Start by typing a question below.
